The S&P 500 rose in choppy trading after the Federal Reserve signaled that the risks for an economic slowdown and higher ...

Ousia Pharma logo Omega Funds Logo . Pioneering a first-in-class drug-targeting approach that leverages hormone analogues to deliver small-molecule neuroplas ...

Pioneering a first-in-class drug-targeting approach that leverages hormone analogues to deliver small-molecule neuroplasticity modulators directly to the brain's appetite control centersFinancing ...

The ballooning obesity drug market may have a new contender after Roche struck a $5.3 billion deal to develop Danish ...

Whether with €1 bulbs or 85 pence hot dogs, Ikea's knack for going against the grain has kept it in business for 82 years.

Novo Nordisk Fonden sender bevilling på i alt 400 millioner kroner til Den Danske Naturfond og Den Danske Klimaskovfond. En samlet bevilling på 400 millioner kroner er sendt til Den Danske Naturfond ...

Novo Nordisk has filed 111 lawsuits in 32 states to stop the sale of dangerous, mislabeled, or impurity-laden knockoff semaglutide drugs. Feel unsure about the market’s next move? Copy trade ...

Novo Nordisk scored a huge legal victory that largely restricts compounding pharmacies from marketing or selling cheaper, unapproved versions of the drugmaker's blockbuster weight loss drug Wegovy ...

Novo Nordisk (NYSE: NVO), the Danish drugmaker of GLP-1 weight loss drugs Ozempic and Wegovy, slipped 2% through 10:30 a.m. ET Friday after suffering a one-two punch from Reuters and a bank analyst.